ASX News Health Care Cynata’s stem cell tech verified in peer-reviewed study Cynata Therapeutics (ASX:CYP) has had its induced pluripotent stem cell (iPSC) derived mesenchymal stem cell (MSCs)… 2 mins05 February 2025 11:45 (AEDT)